$2.23
-0.06-2.62%
At Close: -
$2.22
-0.0100-0.45%
After Hours: 4:17 PM EDT
15 minutes delayed
Dermata Therapeutics
DRMANASDAQ
Dermata Therapeutics (DRMA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDermata Therapeutics (NASDAQ:DRMA) Stock Quotes, Forecast and News Summary
Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.
| Open | $2.30 |
| Close | $2.23 |
| Volume / Avg. | 22.16K / 33.57K |
| Day Range | 2.23 - 2.41 |
| 52 Wk Range | 2.10 - 26.55 |
| Market Cap | $985.80K |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 31 |
| Short Interest | 4.77% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Dermata Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, dev...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Dermata Therapeutics (DRMA) stock?
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Who are Dermata Therapeutics (DRMA) competitors?
Other companies in Dermata Therapeutics’s space includes: Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Scinai Immunotherapeutics (NASDAQ:SCNI).
What is the target price for Dermata Therapeutics (DRMA) stock?
There is no analysis for Dermata Therapeutics.
What is the forecast for Dermata Therapeutics (DRMA) stock?
Dermata Therapeutics has a consensus price target of $9.00.
Current stock price for Dermata Therapeutics (DRMA)?
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $2.22 last updated July 2, 2024 at 4:17 PM EDT.
Does Dermata Therapeutics (DRMA) pay a dividend?
There are no upcoming dividends for Dermata Therapeutics.
When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?
Dermata Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Dermata Therapeutics (DRMA) going to split?
There is no upcoming split for Dermata Therapeutics.
What sector and industry does Dermata Therapeutics (DRMA) operate in?
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.